tiprankstipranks
Trending News
More News >
Amicus Therapeutics (FOLD)
NASDAQ:FOLD
US Market

Amicus (FOLD) Blogger Opinions & Sentiment

Compare
1,100 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
FOLD Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
40% SeekingAlpha
40% Zacks
20% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Amicus Therapeutics: Moving Towards Consistent Profitability
SeekingAlpha
Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns
Zacks
Amicus Therapeutics: Turning The Corner To Profitability With 2 Developing Therapies
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of FOLD?
Seeking Alpha’s Out of Ignorance has a Bullish Sentiment.
    What do Motley Fool contributors think of FOLD?
    Currently there's no blogger sentiment for FOLD.
    What Is FOLD’s Blogger Sentiment?
    FOLD’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for FOLD?
      The most recent blogger prediction for FOLD was made by Bret Jensen, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          UNHUnitedHealth
          RYTMRhythm Pharmaceuticals
          CVSCVS Health
          NVONovo Nordisk
          KYTXKyverna Therapeutics, Inc.